Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma

NCT06315101 is registered in ClinicalTrials.gov with Guangzhou University of Chinese Medicine as lead sponsor.

NCT NCT06315101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
Guangzhou University of Chinese Medicine
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
December 31, 2023
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable hepatocellular carcinoma